ZA859070B - Detection and isolation of descrete,transmissible,mammalian genes associated with tumor metastasis - Google Patents

Detection and isolation of descrete,transmissible,mammalian genes associated with tumor metastasis

Info

Publication number
ZA859070B
ZA859070B ZA859070A ZA859070A ZA859070B ZA 859070 B ZA859070 B ZA 859070B ZA 859070 A ZA859070 A ZA 859070A ZA 859070 A ZA859070 A ZA 859070A ZA 859070 B ZA859070 B ZA 859070B
Authority
ZA
South Africa
Prior art keywords
descrete
transmissible
isolation
detection
tumor metastasis
Prior art date
Application number
ZA859070A
Other languages
English (en)
Inventor
Shelly C Bernstein
Robert A Weinberg
Original Assignee
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst filed Critical Whitehead Biomedical Inst
Publication of ZA859070B publication Critical patent/ZA859070B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
ZA859070A 1984-11-30 1985-11-27 Detection and isolation of descrete,transmissible,mammalian genes associated with tumor metastasis ZA859070B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30

Publications (1)

Publication Number Publication Date
ZA859070B true ZA859070B (en) 1986-07-30

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA859070A ZA859070B (en) 1984-11-30 1985-11-27 Detection and isolation of descrete,transmissible,mammalian genes associated with tumor metastasis

Country Status (13)

Country Link
EP (1) EP0203970A1 (OSRAM)
JP (1) JPS62501399A (OSRAM)
AU (1) AU5197986A (OSRAM)
DK (1) DK359486A (OSRAM)
ES (1) ES8705043A1 (OSRAM)
FI (1) FI863095L (OSRAM)
GR (1) GR852864B (OSRAM)
HU (1) HUT41837A (OSRAM)
IL (1) IL77157A0 (OSRAM)
NO (1) NO863066L (OSRAM)
PT (1) PT81584B (OSRAM)
WO (1) WO1986003226A1 (OSRAM)
ZA (1) ZA859070B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
WO1991005793A1 (en) 1989-10-18 1991-05-02 The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce Production and use of human nm23 protein and antibodies therefor
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
DE69630142D1 (de) * 1995-11-16 2003-10-30 Baylor College Medicine Verfahren zur identifizierung metastatischer sequenzen
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
US6875429B1 (en) * 1996-01-10 2005-04-05 University Of Liverpool Metastasis inducing DNA's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
WO1999022773A2 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
US6545139B1 (en) 1998-03-13 2003-04-08 Baylor College Of Medicine DNA sequence encoding the p99 gene and kits for the detection of neoplasia
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
DK359486D0 (da) 1986-07-29
PT81584B (en) 1987-04-07
NO863066D0 (no) 1986-07-29
GR852864B (OSRAM) 1986-03-28
HUT41837A (en) 1987-05-28
FI863095A0 (fi) 1986-07-29
JPS62501399A (ja) 1987-06-11
IL77157A0 (en) 1986-04-29
DK359486A (da) 1986-07-29
EP0203970A1 (en) 1986-12-10
FI863095A7 (fi) 1986-07-29
ES549438A0 (es) 1987-04-16
AU5197986A (en) 1986-06-18
PT81584A (en) 1985-12-01
WO1986003226A1 (en) 1986-06-05
ES8705043A1 (es) 1987-04-16
NO863066L (no) 1986-09-29
FI863095L (fi) 1986-07-29

Similar Documents

Publication Publication Date Title
US4581247B1 (en) Lining of pipelines and passageways
AU5310586A (en) Improved sandwich hybridsation technique for the detection of nucleotide sequences
JPS55144885A (en) Recirculation of enzyme
JPS57202289A (en) Culturing of uncourage dependent cell
IL62728A0 (en) Assay for the determination of enzymes
GB8400364D0 (en) Lining of pipelines and passageways
PT81584B (en) Process for the isolation and detection of discrete mammalian genes associated with tumor metastases
JPS56140893A (en) Production of gene modified microorganism
DE3063779D1 (en) Xanthanase enzyme and its production
IL82930A (en) Antibodies for the detection of mammalian carcinomas and their preparation
AU6622586A (en) Method of assaying the presence of cancer cells
JPS5768782A (en) Instantaneous culture medium and sterization thereof
GB2189598B (en) Determination of identity between two organisms
GB2154246B (en) Improved method of culturing cells
GB2168705B (en) Novel bacteriolytic enzyme and process for preparing the same
DE3262764D1 (en) Floating assembly composed of single pontoons coupled together, and assembly keys therefor
GB2103220B (en) 27-desamidosecretin and production of same through recombinant dna technique
JPS57118791A (en) Stabilized enzyme preparation and production thereof
DE3380698D1 (en) Improved enzyme assay and method
JPS57152899A (en) Detection and utilization of enzyme
JPS56128739A (en) Manufacture of diaminodiphenylmethane and higher homologues
GB8526818D0 (en) Operation of bioreactor
IE842443L (en) Detection of nucleic acid.
IL82930A0 (en) Antibodies for the detection of mammalian carcinoma
JPS5523940A (en) Forcing culture installation of alfalfa *lucerne*